Prosecution Insights
Last updated: April 19, 2026
Application No. 17/856,029

AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES

Final Rejection §103§112
Filed
Jul 01, 2022
Examiner
JOHNSON, DANIELLE D
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Spogen Biotech Inc.
OA Round
2 (Final)
44%
Grant Probability
Moderate
3-4
OA Rounds
4y 3m
To Grant
57%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allow Rate
314 granted / 710 resolved
-15.8% vs TC avg
Moderate +13% lift
Without
With
+13.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
57 currently pending
Career history
767
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
55.3%
+15.3% vs TC avg
§102
10.7%
-29.3% vs TC avg
§112
22.1%
-17.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 710 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicants amendment filed 11/18/2025 has been entered. Claims 128, 129, 143 and 147 were amended. Claims 127-132 and 134-157 are pending. Claims 132, 137 and 149-157 are withdrawn. Claims 127-131, 134-136 and 138-148 are under examination Information Disclosure Statement The information disclosure statement (IDS) submitted on 11/18/2025 are in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement has been considered by the examiner. Withdrawn rejections Applicant's amendments and arguments filed 11/18/2025 are acknowledged and have been fully considered. Any rejection and/or objection not specifically addressed below is herein withdrawn. Applicants amendment to claim 129 has necessitated a new rejection. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 129 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 129 recites the limitations "the osmoprotectant", “the anti-dessiccant” and “the anti-respirant” in reference to a kit. There is insufficient antecedent basis for this limitation in the claim. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 127-131, 134-136, 138-146 and 148 are rejected under 35 U.S.C. 103 as being unpatentable over Svec et al. (US 6,241,795; patented Jun 5, 2001) in view of Vriesema et al. (8,419,820; published July 29, 2010) as evidenced by Smith et al. (US 2012/0103051; published May 3, 2012). Applicant’s Invention Applicant claims an agricultural composition comprising and osmoprotectant comprising proline, an anti-desiccant potassium phosphate tribasic, and an anti-respirant comprising alkyl phenol ethoxylate (claim 127). Applicant also claims an agricultural composition comprising and osmoprotectant comprising proline, an anti-desiccant potassium phosphate tribasic, an anti-respirant comprising non-ionic surfactant and a second osmoprotectant betaine (claim 128) Applicant claims kit comprising an osmoprotectant comprising proline, an anti-desiccant potassium phosphate tribasic, and an anti-respirant comprising a non-ionic surfactant, and optionally a second osmoprotectant betaine (claim 127). Determination of the scope and the content of the prior art (MPEP 2141.01) With respect to claims 127-129, 135, 136, 138-142, 145, 146 and 148 of the instant application, Svec et al. teach a dry, concentrated fertilizer comprising vitamins and amino acids which is readily water-soluble and a method of applying the solubilized dilute fertilizer to crops to enhance crop production (abstract). The amino acids are present in an amount of about 0.01% to about 10%, by weight of the fertilizer and are selected from betaines, proline and mixtures thereof (column 2, line 66 through column 3, line 7). The adjuvant used in the dry fertilizer include alkoxylated alkylphenol resins in an amount which totals about 0.1 to about 10%, by weight of the fertilizer (column 3, lines 28-47). Additionally, the macronutrients include nitrogen, phosphorus and potassium compounds selected from potassium phosphate in a total amount of about 10% to about 80%, by weight of the dry fertilizer (column 3, line 48 through column 4, line 7). A variety of secondary and micronutrients such as magnesium nitrate may also be added in total amounts of about 1% to about 3% by weight of the total dry formulations (column 4, lines 8-17). Other additives include wetting-agents, surfactants and other additives known to one of ordinary skill (column 4, lines 22-25). The dry, water soluble fertilizer is useful for foliar application and the amino acids are provided by seaweed extracts purchased from dry or liquid forms (column 4, lines 39-67). The diluted form is prepared by dissolving the dry formulation in water at a ratio of 1 part fertilizer to about 4 to about 600 parts water or more, generally 3-10 pounds per acre when applied by foliar application (column 5, lines 6-15). Therefore, the concentrate and ready to use formulations are contemplated by Svec et al. With respect to claim 129, it is well-settled law that combining printed instructions and an old product into a kit will not render the claimed invention nonobvious even if the instructions detail a new use for the product. See In re Ngai, 367 F.3d 1336, 1339, 70 USPQ2d 1862, 1864 (Fed. Cir. 2004). Therefore a kit comprising an osmoprotectant comprising proline, an anti-desiccant potassium phosphate tribasic, and an anti-respirant comprising a non-ionic surfactant, and optionally a second osmoprotectant betaine would have been prima facie obvious to one of ordinary skill in the art. With respect to claims 143 and 144, Svec et al. encompasses betaine (MW 117.15 g/mol) and proline (MW 115.13 g/mol) in a concentration of about 5 µM to about 100mM total molarity since a dry fertilizer comprising 1% betaine and 1% proline diluted in a ratio of 100 mL of water would be within the concentration range. With respect to claim 130, 131 and 134 Svec et al. teaches proline and betaine but does not specify L-proline or betaine hydrochloride, however, as evidenced by Smith et al. (US 2012/0103051; published May 3, 2012) fertilizer compositions comprising amino acids generally comprise betaine hydrochloride and L-proline [0025]. Therefore, selecting L-proline and betaine hydrochloride would have been prima facie obvious to one of ordinary skill in the art since they are commercially available sources of betaine and proline. Ascertainment of the difference between the prior art and the claims (MPEP 2141.02) Svec et al. teach potassium phosphates but does not specify potassium phosphate tribasic. It is for this reason that Vriesema et al. is joined. Vriesema et al. teach fast dissolving water soluble fertilizers which demonstrate improved solubility (abstract). Tripotassium phosphate (tribasic) is known as an anti-caking agent (column 2, lines 13-34). The water-soluble fertilizers preferably include Tripotassium phosphate (tribasic) as a basic fertilizer in the solid fertilizer product (column 7, lines 26-34; Table 2). The basic fertilizer comprises at least 5% of the composition in the preferred embodiments (column 10, lines 2-6). Finding of prima facie obviousness Rationale and Motivation (MPEP 2142-2143) Svec et al. and Vriesema et al. both teach water soluble fertilizers comprising potassium phosphates. Therefore, it would have been prima facie obvious to one of ordinary skill to combine the teachings of Svec et al. and Vriesema et al. to include potassium phosphate tribasic (tripotassium phosphate) with a reasonable expectation of success. One of ordinary skill would have been motivated at the time of filing to combine the teachings of Svec et al. and Vriesema et al. to further include tribasic potassium phosphate because Vriesema et al. teach that tribasic potassium phosphate is preferred and has anti-caking properties which will allow the product to more readily dissolve in solution. Claim 147 is rejected under 35 U.S.C. 103 as being unpatentable over Svec et al. (US 6,241,795; patented Jun 5, 2001) in view of Vriesema et al. (8,419,820; published July 29, 2010), as applied to claims 127-131, 134-136, 138-146 and 148 in view of Wu et al. (CN102293137; published December 28, 2011). Applicant’s Invention Applicant claims an agricultural composition comprising and osmoprotectant comprising proline, an anti-desiccant potassium phosphate tribasic, and an anti-respirant comprising alkyl phenol ethoxylate (claim 127). Applicant also claims an agricultural composition comprising and osmoprotectant comprising proline, an anti-desiccant potassium phosphate tribasic, an anti-respirant comprising non-ionic surfactant and a second osmoprotectant betaine (claim 128) Determination of the scope and the content of the prior art (MPEP 2141.01) The teachings of Svec et al. and Vriesema et al. are addressed in the above 103 rejection. Ascertainment of the difference between the prior art and the claims (MPEP 2141.02) Svec et al. and Vriesema et al. do not teach the addition of a fungicide that is a conazole claimed by claim 147. It is for this reason that Wu et al. is joined. Wu et al. teach a method of treating kiwi disease with a solid or biological fertilizer nitrogen-phosphorus-potassium, amino acids including proline and propiconazole(summary of invention, paragraph 2-6). The control agent comprises a solid biological fertilizer, a liquid foliar fertilizer and a drying agent composed of amino acids and 25% propiconazole (detailed description, paragraph 2). The amino acid comprises 3 mg of proline (detailed description, paragraph 3). Finding of prima facie obviousness Rationale and Motivation (MPEP 2142-2143) Svec et al., Vriesema et al. and Wu et al. all teach fertilizer formulations. Therefore, it would have been prima facie obvious to one of ordinary skill to combine the teachings of Svec et al., Vriesema et al. and Wu et al. to use a conazole fungicide with a reasonable expectation of success. One of ordinary skill would have been motivated at the time of filing to combine the teachings of Svec et al., Vriesema et al. and Wu et al. to further include propiconzole because Wu et al. teach that combining proline and propiconazole with nitrogen-phosphorus-potassium fertilizers treat disease and improve plant health in kiwi. Response to Arguments Applicant's arguments filed 11/18/2025 have been fully considered but they are not persuasive. Applicant argues there is nothing in Svec et al. to teach or suggest selectively using proline or a combination of proline and betaine as osmoprotectants. The Examiner is not persuaded by this argument because Svec teaches proline and betaine are amino acids present in an amount of about 0.01% to about 10%, by weight of the fertilizer (column 2, line 66 through column 3, line 7) and amino acids such as proline and betaine are known to inherently possess properties as osmoprotectants. Applicant further argues that Svec et al. teach the growth promoters and amino acids are supplied by seaweed extracts not sources of single amino acids which would have higher total amino acid content. The Examiner is not persuaded by this argument because Svec teaches optimizing the amount of proline and betaine to about 0.01-10% to enhance crop production. The comprising language of the claim allows for the inclusion of other components which include seaweed extracts. Applicant further argues that there is no motivation in Smith to select betaine hydrochloride and L-proline because Smith teach calcium hypophosphite is provides a more stable product and contains fewer degradation products. The Examiner is not persuaded by this argument because Smith et al. states that fertilizer compositions comprising amino acids generally comprise betaine hydrochloride and L-proline [0025]. Therefore, one of ordinary skill in the art would have preferred betaine selected from betaine hydrochloride and proline selected from L-proline to form a fertilizer. Applicant argues there is not suggestion or motivation in Vriesema to selectively use potassium phosphate tribasic in a fertilizer that does not comprise an acidic component. The Examiner is not persuaded by this argument because Vriesema teach tripotassium phosphate (tribasic) is known as an anti-caking agent (column 2, lines 13-34) and fertilizers preferably include tripotassium phosphate (tribasic) as a basic fertilizer in the solid fertilizer product (column 7, lines 26-34; Table 2). The comprising language of the claim allows for the inclusion of other components including acidic components. Therefore the present claims are prima facie obvious. Finally, Applicant argues that Wu et al. provides no motivation to combine a conazole fungicide into the composition since it is administered separately and at different times than the other fertilizers. The Examiner is not persuaded by this argument because Wu et al. teach that combining proline and propiconazole with nitrogen-phosphorus-potassium fertilizers treat disease and improve plant health in kiwi. It would be prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose in order to form a third composition that is to be used for the very same purpose, the idea of combining them flows logically from their having been individually taught in prior art.” In re Kerkhoven 205 USPQ 1069, (C.C.P.A. 1980). Therefore, there rejections have been maintained. Conclusion No claims allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DANIELLE D JOHNSON whose telephone number is (571)270-3285. The examiner can normally be reached Monday-Friday 9:00 am-5:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bethany Barham can be reached at 571-272-6175. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. DANIELLE D. JOHNSON Examiner Art Unit 1611 /BETHANY P BARHAM/Supervisory Patent Examiner, Art Unit 1611
Read full office action

Prosecution Timeline

Jul 01, 2022
Application Filed
Jul 01, 2022
Response after Non-Final Action
Aug 07, 2025
Non-Final Rejection — §103, §112
Nov 18, 2025
Response Filed
Mar 03, 2026
Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599141
ROD-SHAPED PLANT VIRAL NANOPARTICLES OR VIRUS-LIKE PARTICLES FOR AGRICULTURAL APPLICATIONS
2y 5m to grant Granted Apr 14, 2026
Patent 12595394
PLA / PHA BIODEGRADABLE COATINGS FOR SEEDS AND FERTILIZERS
2y 5m to grant Granted Apr 07, 2026
Patent 12582117
ENCAPSULATION OF LARVICIDES INTO BIOPOLYMER CAPSULES
2y 5m to grant Granted Mar 24, 2026
Patent 12577216
TRIAZINE BENZOATE COMPOUND AND APPLICATION THEREOF
2y 5m to grant Granted Mar 17, 2026
Patent 12486216
PROCESSES FOR PREPARING NITROSYLATED PROPANEDIOLS, COMPOSITIONS COMPRISING THE SAME, AND MEDICAL USES THEREOF
2y 5m to grant Granted Dec 02, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
44%
Grant Probability
57%
With Interview (+13.0%)
4y 3m
Median Time to Grant
Moderate
PTA Risk
Based on 710 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month